Calithera Biosciences, Inc.
CALA · OTC
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $16 | $14 | $14 | $32 |
| - Cash | $25 | $34 | $42 | $45 |
| + Debt | $2 | $2 | $2 | $3 |
| Enterprise Value | -$8 | -$18 | -$25 | -$10 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$7 | -$9 | -$11 | -$14 |
| % Margin | – | – | – | – |
| Net Income | -$7 | -$10 | $10 | -$14 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.42 | -2.01 | 1.79 | -3.53 |
| % Growth | 29.4% | -212.3% | 150.7% | – |
| Operating Cash Flow | -$9 | -$8 | -$11 | -$16 |
| Capital Expenditures | -$0 | $0 | -$0 | $0 |
| Free Cash Flow | -$9 | -$8 | -$11 | -$16 |